6 Pharma Trends for 2025: Trump’s Return, AI Breakthroughs, and Market Access Challenges
Pharma is facing a new set of launch, market access and strategic challenges as the pandemic has changed some market characteristics for good.
 An agile launch execution platform, with full visibility across countries and
                                functions.
                            An agile launch execution platform, with full visibility across countries and
                                functions.
                        
                     A collaborative platform for teams who plan reimbursements and HTA activities.
                            A collaborative platform for teams who plan reimbursements and HTA activities.
                        
                     A collaborative platform designed to manage pharmaceutical tenders across
                                countries.
                            A collaborative platform designed to manage pharmaceutical tenders across
                                countries.
                        
                     A capability management platform that unifies capabilities, resources, and assessment.
                            A capability management platform that unifies capabilities, resources, and assessment.
                        
                     Manage your entire pipeline. Track every move. Stay ahead, from discovery to launch.
                            Manage your entire pipeline. Track every move. Stay ahead, from discovery to launch.
                        
                    Our products
 Andre Moa
                                                    Andre Moa
                                                 21 Jan 2025
                                                    21 Jan 2025
                                                 21 minute read
                                                    21 minute read
                                                Pharma is facing a new set of launch, market access and strategic challenges as the pandemic has changed some market characteristics for good.
Pharmaceutical companies must ensure that each component of their product launch plan makes a meaningful contribution to return on investment (ROI).
By optimising the efficiency and impact of a launch programme, you can maintain ROI from new products at realistic levels that will keep R&D ticking over and continue providing incentives for pharma companies and their investors to pursue better health outcomes.
Medicines need to make a profit. Making launches count: pharma and biotech ROI under strain
Collaboration is a key pillar of a successful pharma launch - watch out for these 5 signs that your launch team is not collaborating effectively.
Global value dossiers are the key to getting your products to market but when they’re done badly, they waste valuable time and resource.
Successful market access team collaboration requires the backing of the whole business - here are tips for effecitve execution.
TRiBECA Knowledge needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Notice.